Transverse leukonychia (mees' lines) due to daunorubicin chemotherapy

Pediatric Dermatology

Volumn 14, Issue 2, 1997, Pages 144-145

  Shelley, Walter B ^a   Humphrey, G Bennett ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; METHOTREXATE; TIOGUANINE; VINCRISTINE SULFATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CHILD; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NAIL DISEASE; PRIORITY JOURNAL;

EID: 0030999880     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1470.1997.tb00222.x     Document Type: Article

References (8)

1. Baran R, Dawber RPR, eds. Disease of the nails and their management. London: Blackwell Scientific, 1994.
2. Scher RD, Daniel CR III, eds. Nails: therapy, diagnosis, surgery. Philadelphia: WB Saunders, 1990.
3. Baran R, Perrin C. Transverse leukonychia of toenails due to repeated microtrauma. Br J Dermatol 1995;133:267-269.
4. James WD, Odom RB. Chemotherapy-induced transverse white lines in the fingernails. Arch Dermatol 1983;119: 334-335.
5. Unamuno P, Fernandez-Lopez E, Santos C. Leukonychia due to cytostatic agents. Clin Exp Dermatol 1992;17: 273-274.
6. Miles DW, Rubens RD. Transverse leukonychia. N Eng J Med 1995;333:100.
7. Haskell, CM. Cancer treatment, 4th ed. Philadelphia: WB Saunders, 1995.
8. DeMarinis M, Hendricks A, Stoltzner G. Nail pigmentation with daunorubicin therapy. Ann Int Med 1978;89:516-617.